cardiac arrest
Conditions
Brief summary
Cumulative incidence of weaning from vasopressors at day 3 after OHCA.
Detailed description
Cumulative incidence of death by refractory shock within 7 days after OHCA., the neurological outcome at day 28 after OHCA, assessed using the mRS (favorable neurological outcome will be considered if mRS range from 0 to 3; Unfavorable neurological outcome will be considered if mRS range from 4 to 6)., The maximal vasopressors infusion dose within 3 days after OHCA., The delta SOFA (sepsis-related organ failure assessment score) is defined as the difference between SOFA admission and SOFA at 72 hours after OHCA. Death within 72 hours will be counted as the maximum SOFA score (i.e. 24 points)., The lower arterial lactate level at day 3 after OHCA.
Interventions
Sponsors
Eligibility
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Cumulative incidence of death by refractory shock within 7 days after OHCA., the neurological outcome at day 28 after OHCA, assessed using the mRS (favorable neurological outcome will be considered if mRS range from 0 to 3; Unfavorable neurological outcome will be considered if mRS range from 4 to 6)., The maximal vasopressors infusion dose within 3 days after OHCA., The delta SOFA (sepsis-related organ failure assessment score) is defined as the difference between SOFA admission and SOFA at 72 hours after OHCA. Death within 72 hours will be counted as the maximum SOFA score (i.e. 24 points)., The lower arterial lactate level at day 3 after OHCA. | — |
Primary
| Measure | Time frame |
|---|---|
| Cumulative incidence of weaning from vasopressors at day 3 after OHCA. | — |
Countries
France